Respiratory Institute Outcomes
Thoracic Oncology (Lung Cancer)
Lung Cancer Screening Program
The primary goal of low-dose computed tomography (LDCT) lung cancer screening is to detect lung cancer at curable stages while minimizing harm to those without lung cancer. Since 2015, Cleveland Clinic’s lung cancer screening program has performed > 24,000 LDCTs, with > 6,500 individuals screened in 2022. More than 340 lung cancers have been diagnosed through screening since the program began.
In 2022, our centralized program grew to a total of 17 sites. Adherence to annual follow-up was impacted by the COVID-19 pandemic but overall follow-up remained high. Despite 9% of screening exams being category 4, fewer than 0.5% of those screened have had an invasive procedure performed for a benign finding. We continue to strive to provide the highest quality of care to those being screened while growing through adopting the expanded eligibility criteria of the United States Preventive Services Task Force (USPSTF) and increasing our outreach efforts.¹
Cleveland Clinic Respiratory Institute hosts two different podcasts, available on Apple, Google, Soundcloud and Spotify. Click on a link below to find and listen to the following podcasts:
‘Should You Be Screened for Lung Cancer?’ and ‘Lung Cancer Screening: It’s More Than a CT Scan’ hosted by Raed Dweik, MD, MBA, Chair of the Respiratory Institute at Cleveland Clinic, with guest Peter Mazzone, MD, MPH, Section Head of Thoracic Oncology, Program Director of Lung Cancer Screening at Cleveland Clinic.
- Respiratory Exchange. For our medical professionals audience, visit: https://my.clevelandclinic.org/podcasts/respiratory-exchange
- Respiratory Inspirations. Suitable for any audience interested in learning more about conditions affecting your respiratory health as we discuss related diseases, causes, treatments, innovations and what the future may bring. Visit: https://my.clevelandclinic.org/podcasts/respiratory-inspirations
The Percentage of Individuals Who Complete LDCT Screening for Lung Cancer Who are Screen-Eligible Based on the USPSTF Criteria
* of 2617
** of 2953
Percentage of Individuals Who Currently Smoke Who Participated in LDCT Screening That Have Documentation of a Smoking Cessation Intervention¹ (N = 6519)
¹Based on percentage of individuals who currently smoke who participate in LDCT screening who have documentation of a smoking cessation intervention (e.g. discussion, an offer to participate in a smoking cessation program) during the shared decision-making visit.
Percentage of Lung Cancer LDCT Screen Eligible Individuals who Complete a LDCT Exam and are Identified to Have Lung-RADS® Category 1 or 2 Findings who Complete the Next Annual LDCT Screening Exam (N = 3285)
Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a Lung-RADS® Category 3 Nodule in Which a Surveillance LDCT Scan is Performed at 6 Months (+/- 2 months) (N = 324)
Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a Lung-RADS® Category 4 (A) Nodule in Which a Surveillance LDCT Scan, CT Scan, or PET Scan is Performed at 3 Months (+/- 6 weeks) (N = 230)
Time from Identification of a Lung-RADS® Category 4B or 4X Lung Nodule/Mass on a LDCT Screening Exam to the Diagnosis of Lung Cancer (N = 39)